NQ-1065

N/A

Report date: 2025/01/26 16:16:34
NME

Base Information

Drug NameNQ-1065
Drug Alias Namesmall molecule therapeutics (NeuroQuest)NQ-1065
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit modulatorsTransient receptor potential channels inhibitors
TargetsSodium channel protein type IX alpha subunitTransient receptor potential channels
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuroQuest Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuroQuest Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A